Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (36 ops.)
Latest filing published 20 Jan 2021 for Constellation Pharmaceuticals INC, €164k.
Filing timeline
BuySaleKaren Valentine
Insider track record
Disclosed buys
0
Disclosed sells
36
Signal history
Karen Valentine: trading record in brief
Karen Valentine is a declared insider at 2 companies; the most frequent names are Agenus Inc and Constellation Pharmaceuticals Inc. Over a trading history stretching from 10 July 2008 to 19 January 2021, the count stands at 95 filings.
No open-market purchase appears, only 36 sales worth €3.2M. The rest of the record consists of 32 share grants and 18 option exercises. In 2021 alone, the filings show no purchases and 3 sales.
Most recently, on 20 January 2021, the filings show an option exercise worth €164k in Constellation Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Karen Valentine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations79 total
17,203 shares@ US$11.505.2% of flowCommon StockSEC:0001562180-21-000392:0
8,773 shares@ US$33.087.7% of flowCommon StockSEC:0001562180-21-000392:1
1,227 shares@ US$33.691.1% of flowCommon StockSEC:0001562180-21-000392:2
7,203 shares@ US$35.116.7% of flowCommon StockSEC:0001562180-21-000392:3
4,744 shares@ US$11.501.5% of flowCommon StockSEC:0001562180-20-003453:0
4,744 shares@ US$40.015.3% of flowCommon StockSEC:0001562180-20-003453:1
10,099 shares@ US$11.503.3% of flowCommon StockSEC:0001562180-20-003453:2
2,467 shares@ US$8.760.6% of flowCommon StockSEC:0001562180-20-003453:3
12,566 shares@ US$40.1014.2% of flowCommon StockSEC:0001562180-20-003453:4
400 shares@ US$11.500.1% of flowCommon StockSEC:0001562180-20-003207:0
400 shares@ US$40.130.5% of flowCommon StockSEC:0001562180-20-003207:1
789 shares@ US$11.500.3% of flowCommon StockSEC:0001562180-20-003096:0
789 shares@ US$33.650.7% of flowCommon StockSEC:0001562180-20-003096:1
2,998 shares@ US$11.501.0% of flowCommon StockSEC:0001562180-20-003062:0
1,955 shares@ US$33.291.8% of flowCommon StockSEC:0001562180-20-003062:1
1,043 shares@ US$34.091.0% of flowCommon StockSEC:0001562180-20-003062:2
2,300 shares@ US$11.500.7% of flowCommon StockSEC:0001562180-20-003062:3
2,300 shares@ US$35.192.3% of flowCommon StockSEC:0001562180-20-003062:4
635 shares@ US$8.760.2% of flowCommon StockSEC:0001562180-20-002991:0
635 shares@ US$35.020.6% of flowCommon StockSEC:0001562180-20-002991:1
617 shares@ US$8.760.1% of flowCommon StockSEC:0001562180-20-002396:0
152 shares@ US$31.170.1% of flowCommon StockSEC:0001562180-20-002396:1
335 shares@ US$32.080.3% of flowCommon StockSEC:0001562180-20-002396:2
130 shares@ US$32.920.1% of flowCommon StockSEC:0001562180-20-002396:3
1,500 shares@ US$11.500.5% of flowCommon StockSEC:0001562180-20-001250:0
25 of 79 declarations
